Jazz Pharmaceuticals plc (JAZZ)
NASDAQ: JAZZ · IEX Real-Time Price · USD
109.01
+0.17 (0.16%)
At close: Jul 19, 2024, 4:00 PM
109.06
+0.05 (0.05%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Jazz Pharmaceuticals Stock Forecast
Stock Price Forecast
The 15 analysts with 12-month price forecasts for JAZZ stock have an average target of 185.47, with a low estimate of 113 and a high estimate of 230. The average target predicts an increase of 70.14% from the current stock price of 109.01.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for JAZZ stock from 16 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 6 | 6 |
| Buy | 6 | 7 | 7 | 7 | 7 | 7 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 15 | 15 | 15 | 16 | 16 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Hold Maintains $160 → $150 | Hold | Maintains | $160 → $150 | +37.60% | Jul 12, 2024 |
| UBS | UBS | Hold Maintains $117 → $113 | Hold | Maintains | $117 → $113 | +3.66% | Jul 2, 2024 |
| Needham | Needham | Strong Buy Maintains $222 → $210 | Strong Buy | Maintains | $222 → $210 | +92.64% | Jun 20, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy Initiates $169 | Strong Buy | Initiates | $169 | +55.03% | Jun 5, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $200 | Strong Buy | Reiterates | $200 | +83.47% | May 3, 2024 |
Financial Forecast
Revenue This Year
4.13B
from 3.83B
Increased by 7.77%
Revenue Next Year
4.44B
from 4.13B
Increased by 7.55%
EPS This Year
18.92
from 6.10
Increased by 210.11%
EPS Next Year
21.23
from 18.92
Increased by 12.23%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 4.3B | 4.9B | 5.3B | 5.6B | 6.2B |
| Avg | 4.1B | 4.4B | 4.7B | 4.9B | 5.2B |
| Low | 3.9B | 3.9B | 4.1B | 4.2B | 4.1B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 12.6% | 18.3% | 20.0% | 20.2% | 26.6% |
| Avg | 7.8% | 7.6% | 5.2% | 4.7% | 5.6% |
| Low | 2.3% | -5.6% | -6.8% | -9.9% | -16.1% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 20.16 | 25.04 | 28.47 | 28.93 | 33.44 |
| Avg | 18.92 | 21.23 | 22.36 | 23.48 | 24.74 |
| Low | 17.79 | 15.78 | 16.11 | 15.67 | 14.83 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 230.5% | 32.4% | 34.1% | 29.4% | 42.4% |
| Avg | 210.1% | 12.2% | 5.3% | 5.0% | 5.4% |
| Low | 191.6% | -16.6% | -24.1% | -29.9% | -36.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.